Lionel Geoffrois
Nancy, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trial.
Journal: The lancet. Healthy longevity
Published: November 27, 2023
Randomized phase II study of preoperative afatinib in untreated head and neck cancers: predictive and pharmacodynamic biomarkers of activity.
Journal: Scientific reports
Published: July 12, 2023
The GETUG SEMITEP Trial: De-escalating Chemotherapy in Good-prognosis Seminoma Based on Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Journal: European urology
Published: January 08, 2022
Impact of Neck Dissection in Head and Neck Squamous Cell Carcinomas of Unknown Primary.
Journal: Cancers
Published: April 12, 2021
Primary Renal Tumour Response in Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma: Results from the GETUG-AFU 26 NIVOREN Trial.
Journal: European urology
Published: January 20, 2021
Cost-effectiveness Analysis of Innovative Therapy for Patients with Newly Diagnosed Hormone-Sensitive Metastatic Prostate Cancer.
Journal: Clinical genitourinary cancer
Published: January 18, 2021
Induction chemotherapy followed by cisplatin or cetuximab concomitant to radiotherapy for laryngeal/hypopharyngeal cancer: Long-term results of the TREMPLIN randomised GORTEC trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 08, 2019
Axitinib in first-line for patients with metastatic papillary renal cell carcinoma: Results of the multicentre, open-label, single-arm, phase II AXIPAP trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 18, 2019
Intrapericardial instillation of bleomycin prevents recurrence of malignant pericardial effusions: Series of 46 cases and comprehensive literature review.
Journal: Bulletin du cancer
Published: February 25, 2019
Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trials.
Journal: Oral oncology
Published: May 14, 2017
Standard or accelerated methotrexate, vinblastine, doxorubicin and cisplatin as neoadjuvant chemotherapy for locally advanced urothelial bladder cancer: Does dose intensity matter?
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 21, 2015
Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial.
Journal: The Lancet. Oncology
Published: December 16, 2014
Last Updated: 09/26/2026